Metraipolis › archive › dc_e5df12c6dc96

Mapping Human Clinical Evidence for Chikungunya Vaccines: A Scoping Review of Immunogenicity, Durability, and Safety — Europe PMC PMID:42506635

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42506635
DOI
10.3390/vaccines14070598
License (as archived)
solo-consultazione
Archived
2026-10-18T10:48:56.964Z
SHA-256 of the archived text
7197a5452141c438a27e14ed1ec70b03d98f222cd80d92140b091a0082bfff14
Stable URL of this page
https://metraipolis.com/documento/dc_e5df12c6dc96

How to cite

Mapping Human Clinical Evidence for Chikungunya Vaccines: A Scoping Review of Immunogenicity, Durability, and Safety — Europe PMC PMID:42506635 — Europe PMC (en), https://europepmc.org/article/MED/42506635 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e5df12c6dc96 (Metraipolis archive dc_e5df12c6dc96, sha256 7197a5452141c438a27e14ed1ec70b03d98f222cd80d92140b091a0082bfff14)
BibTeX
@misc{dce5df12c6dc96,
  title = {Mapping Human Clinical Evidence for Chikungunya Vaccines: A Scoping Review of Immunogenicity, Durability, and Safety — Europe PMC PMID:42506635},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42506635},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e5df12c6dc96; sha256 7197a5452141c438a27e14ed1ec70b03d98f222cd80d92140b091a0082bfff14},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42506635. Agents can read the archived copy with the MCP tool read_document.